Oculoplastics

Teprotumumab increases tear production in patients with TED

Patients with thyroid eye disease (TED) treated with teprotumumab had significant reductions in the volume of lacrimal glands as well as increases in tear production, according to a poster presented at ASOPRS 52nd Annual Fall Scientific Symposium. In this prospective longitudinal study, 20 patients treated with 8 infusions of teprotumumab...